Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study

Carmen Alcalá, Carlos Quintanilla‐Bordás, Francisco Gascón, Ángel Pérez Sempere, Laura Navarro-Cantó, María Carcelén‐Gadea, Lamberto Landete, Javier Mallada, Emmanuel Cañizares, Antonio Belenguer, Sara Carratalà‐Boscà, José Andrés Domínguez, Francisco Pérez‐Miralles, Sara Gil‐Perotín, Raquel Gasqué-Rubio, Laura Cubas-Núñez, J Cabello del Castillo, Bonaventura Casanova